A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas

A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas

Bibliographic Details
Main Authors: Kim, Jeong Eun, Yoon, Dok Hyun, Jang, Geundoo, Lee, Dae Ho, Kim, Shin, Park, Chan-Sik, Huh, Jooryung, Kim, Won Seog, Park, Jinny, Lee, Jae Hoon, Lee, Soon Il, Suh, Cheolwon
Format: Online
Language:English
Published: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317471/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317471/

Similar Items